GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » Price-to-Free-Cash-Flow

Microbix Biosystems (TSX:MBX) Price-to-Free-Cash-Flow : 28.33 (As of May. 20, 2025)


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems Price-to-Free-Cash-Flow?

As of today (2025-05-20), Microbix Biosystems's share price is C$0.34. Microbix Biosystems's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.01. Hence, Microbix Biosystems's Price-to-Free-Cash-Flow Ratio for today is 28.33.

The historical rank and industry rank for Microbix Biosystems's Price-to-Free-Cash-Flow or its related term are showing as below:

TSX:MBX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.67   Med: 115   Max: 640
Current: 28.34

During the past 13 years, Microbix Biosystems's highest Price-to-Free-Cash-Flow Ratio was 640.00. The lowest was 16.67. And the median was 115.00.

TSX:MBX's Price-to-Free-Cash-Flow is ranked better than
51.79% of 224 companies
in the Biotechnology industry
Industry Median: 30.09 vs TSX:MBX: 28.34

Microbix Biosystems's Free Cash Flow per Share for the three months ended in Dec. 2024 was C$0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$0.01.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Microbix Biosystems was 500.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 44.20% per year.

During the past 13 years, Microbix Biosystems's highest 3-Year average Free Cash Flow per Share Growth Rate was 60.10% per year. The lowest was -80.60% per year. And the median was 8.40% per year.


Microbix Biosystems Price-to-Free-Cash-Flow Historical Data

The historical data trend for Microbix Biosystems's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Price-to-Free-Cash-Flow Chart

Microbix Biosystems Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 105.00 51.00 - 18.61

Microbix Biosystems Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 195.00 26.07 100.00 18.61 34.17

Competitive Comparison of Microbix Biosystems's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Microbix Biosystems's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's Price-to-Free-Cash-Flow falls into.


;
;

Microbix Biosystems Price-to-Free-Cash-Flow Calculation

Microbix Biosystems's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.34/0.012
=28.33

Microbix Biosystems's Share Price of today is C$0.34.
Microbix Biosystems's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Microbix Biosystems  (TSX:MBX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Microbix Biosystems Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. There are two operating segments: The development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and; Development and commercialization of novel and proprietary products or technologies such as Kinlytic. Geographically, it derives a majority of revenue from North America and also operates in Europe and other foreign countries.
Executives
James Stuart Currie Senior Officer
Mark Adrian Luscher Senior Officer
Bo Hollas Director
Jennifer Anne Stewart Director
Cameron Lionel Groome Director, Senior Officer
Kenneth Hughes Senior Officer
Martin Marino Director
Peter Martin Blecher Director
Philip Jonathan Casselli Senior Officer
Steven Trevor Hagerman Senior Officer
Damian Klimaszewski Senior Officer
Anthony J. Giovinazzo Director